Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively
You start with the GLP-1 so that you can achieve the maximum weight loss, then because the price is too high to pay for the weight maintenance, you can switch off to less-effective but much more cost-saving strategies, Kim said
Research-grade peptides undergo rigorous quality control measures
The glucagon arm is what distinguishes it from every GLP-1 and dual-agonist compound it increases energy expenditure in addition to the appetite and glycemic effects of the incretin receptors ( Coskun et al., Cell Metab 2022 )
What should I do if I experience GLP-1related depression symptoms
IGF-1 LR3 does not increase growth hormone (GH) levels directly
